4-beta-Laminaribiosylglucose

(2R,3R,4R,5R)-4-[(2S,3R,4S,5S,6R)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-2,3,5,6-tetrahydroxyhexanal

KZZUYHVLNLDKLB-KZCWKWOXSA-N CHEBI:175860 0 Reactome links 1 studies

Metabolite details

Identifier: KZZUYHVLNLDKLB-KZCWKWOXSA-N
InChI Key: KZZUYHVLNLDKLB-KZCWKWOXSA-N
IUPAC name: (2R,3R,4R,5R)-4-[(2S,3R,4S,5S,6R)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-2,3,5,6-tetrahydroxyhexanal
Preferred name: 4-beta-Laminaribiosylglucose
INN name: —
Synonym: —
ChEBI: CHEBI:175860

Reactome pathways

No Reactome pathways listed for this metabolite.

Observed in studies

Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)

Observed in differential profiles

G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47